Targeting the peripheral neural-tumour microenvironment for cancer therapy.

Saved in:
Bibliographic Details
Title: Targeting the peripheral neural-tumour microenvironment for cancer therapy.
Authors: Yaniv D; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mattson B; The Neurodegeneration Consortium, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Talbot S; Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden.; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada., Gleber-Netto FO; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. fonetto@mdanderson.org., Amit M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mamit@mdanderson.org.; UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mamit@mdanderson.org.
Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Oct; Vol. 23 (10), pp. 780-796. Date of Electronic Publication: 2024 Sep 06.
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-1784
DOI:10.1038/s41573-024-01017-z